Canurta Therapeutics

Canurta Therapeutics is a biotech company that has developed a proprietary platform that can produce high-purity botanical compounds for neurodegenerative disease treatments, particularly ALS. Current treatments for ALS often target only a single pathway, leaving patients with limited solutions. Canurta’s CNR 401, deri

Based, Canurta Therapeutics works in neuro.

Profile

Canurta Therapeutics is a biotech company that has developed a proprietary platform that can produce high-purity botanical compounds for neurodegenerative disease treatments, particularly ALS. Current treatments for ALS often target only a single pathway, leaving patients with limited solutions. Canurta’s CNR 401, derived from rare botanical sources like cannflavins, provides a more comprehensive multi-pathway treatment. […]

Its activity falls under neuro; the profile below is assembled from public directory data.

The company is listed at the Creative Destruction Lab alumni company stage of development.

Website: canurta.com